CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Imatinib treatment for patients with advanced stage hepatocellular carcinoma: A multicenter phase II trial
DOI 10.1055/s-0030-1254614
Bibliografische Angaben
Nachweis in CareLit
Autor:innenI Graziadei, A Finkenstedt, R Stauber, C Müller, M Trauner, W Vogel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with limited treatment options in advanced stages. The antitumor activity of systemic chemotherapies in patients with HCC has been disappointing. The aim of this study was to evaluate the safety and efficacy of imatinib, a tyrosine kinase inhibitor, in patients with advanced HCC. Methods: Patients with stage III and IVa/b HCCs wit…
Zitieren
Zitierempfehlung
I Graziadei, A Finkenstedt, R Stauber, C Müller, M Trauner, W Vogel (2010) Imatinib treatment for patients with advanced stage hepatocellular carcinoma: A multicenter phase II trial. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0030-1254614
Mit CareLit weiterarbeiten